PURPOSE: Clinical epidemiology studies increasingly rely on electronic medical records data. The validity of International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis codes is crucial as they are often used to identify conditions of interest. We evaluated the use of archived ICD-9-CM codes to identify two representative infection-related conditions, pneumonia and herpes simplex virus (HSV), in a defined health system. METHODS: Records were obtained for a sample of 175 and 179 patients with ICD-9-CM codes for pneumonia and HSV, respectively. An adjudicated case status was assigned for each subject. RESULTS: The presence of a single ICD-9-CM code had a positive predictive value of 88% for pneumonia and 86% for HSV. False positives (noncases) accounted for less than 10% of records evaluated for each condition. CONCLUSIONS: Our study demonstrates that ICD-9-CM codes for pneumonia and HSV were valid markers of a true history of these conditions, suggesting that ICD-9-CM codes can be used to successfully identify infection-related conditions in epidemiologic studies. However, validation studies for individual conditions may help identify condition-specific strategies to improve the performance of diagnostic codes. Published by Elsevier Inc.
PURPOSE: Clinical epidemiology studies increasingly rely on electronic medical records data. The validity of International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis codes is crucial as they are often used to identify conditions of interest. We evaluated the use of archived ICD-9-CM codes to identify two representative infection-related conditions, pneumonia and herpes simplex virus (HSV), in a defined health system. METHODS: Records were obtained for a sample of 175 and 179 patients with ICD-9-CM codes for pneumonia and HSV, respectively. An adjudicated case status was assigned for each subject. RESULTS: The presence of a single ICD-9-CM code had a positive predictive value of 88% for pneumonia and 86% for HSV. False positives (noncases) accounted for less than 10% of records evaluated for each condition. CONCLUSIONS: Our study demonstrates that ICD-9-CM codes for pneumonia and HSV were valid markers of a true history of these conditions, suggesting that ICD-9-CM codes can be used to successfully identify infection-related conditions in epidemiologic studies. However, validation studies for individual conditions may help identify condition-specific strategies to improve the performance of diagnostic codes. Published by Elsevier Inc.
Authors: F DeStefano; E D Eaker; S K Broste; D L Nordstrom; P L Peissig; R A Vierkant; K A Konitzer; R L Gruber; P M Layde Journal: J Clin Epidemiol Date: 1996-06 Impact factor: 6.437
Authors: S A Skull; R M Andrews; G B Byrnes; D A Campbell; T M Nolan; G V Brown; H A Kelly Journal: Epidemiol Infect Date: 2007-04-20 Impact factor: 2.451
Authors: Leslie R Harrold; Kenneth G Saag; Robert A Yood; Ted R Mikuls; Susan E Andrade; Hassan Fouayzi; Judith Davis; K Arnold Chan; Marsha A Raebel; Ann Von Worley; Richard Platt Journal: Arthritis Rheum Date: 2007-02-15
Authors: Fujie Xu; Julianne M Gee; Allison Naleway; Kenneth M Zangwill; Bradley Ackerson; Eileen Eriksen; Eric S Weintraub; Kathleen Hutchins; Feifei Wei; Stuart M Berman; Lauri E Markowitz Journal: Sex Transm Dis Date: 2008-06 Impact factor: 2.830
Authors: Ewoudt M W van de Garde; Jan Jelrik Oosterheert; Marc Bonten; Robert C Kaplan; Hubert G M Leufkens Journal: J Clin Epidemiol Date: 2007-02-23 Impact factor: 6.437
Authors: Maria F Nunez; Gezzer Ortega; Lucas G Souza Mota; Olubode A Olufajo; Derek W Altema; Terrence M Fullum; Daniel Tran Journal: Am J Surg Date: 2018-12-14 Impact factor: 2.565
Authors: Sara G Murray; Gabriela Schmajuk; Laura Trupin; Erica Lawson; Matthew Cascino; Jennifer Barton; Mary Margaretten; Patricia P Katz; Edward H Yelin; Jinoos Yazdany Journal: Arthritis Care Res (Hoboken) Date: 2015-05 Impact factor: 4.794
Authors: Junichi Ishigami; Ron C Hoogeveen; Christie M Ballantyne; Aaron R Folsom; Josef Coresh; Elizabeth Selvin; Kunihiro Matsushita Journal: Am J Epidemiol Date: 2019-12-31 Impact factor: 4.897
Authors: Aimee M Foord; Kara L Cushing-Haugen; Michael J Boeckh; Paul A Carpenter; Mary E D Flowers; Stephanie J Lee; Wendy M Leisenring; Beth A Mueller; Joshua A Hill; Eric J Chow Journal: Blood Adv Date: 2020-04-14
Authors: Stacy A Trent; Zachary J Jarou; Edward P Havranek; Adit A Ginde; Jason S Haukoos Journal: Acad Emerg Med Date: 2019-01-17 Impact factor: 3.451
Authors: Sarah Reeves; Erika Garcia; Mary Kleyn; Michelle Housey; Robin Stottlemyer; Sarah Lyon-Callo; Kevin John Dombkowski Journal: Acad Pediatr Date: 2014-05-29 Impact factor: 3.107
Authors: Junichi Ishigami; Jonathan Taliercio; Harold I Feldman; Anand Srivastava; Raymond Townsend; Debbie L Cohen; Edward Horwitz; Panduranga Rao; Jeanne Charleston; Jeffrey C Fink; Ana C Ricardo; James Sondheimer; Teresa K Chen; Myles Wolf; Tamara Isakova; Lawrence J Appel; Kunihiro Matsushita Journal: Am J Epidemiol Date: 2020-05-05 Impact factor: 4.897